The results of phase - I of Oxford COVID-19 vaccine trial was published on Monday. Richard Borton, the editor-in-chief of UK-Based medical journal The Lancet, said, "it is safe, well-tolerated and immunogenic." He added that results are extremely encouraging. <br /><br />#Oxford #COVID-19Vaccine #COVID-19VaccinePhase-I<br /><br />Link: https://www.latestly.com/<br /><br />Subscribe: https://www.youtube.com/c/LatestLYIndia<br />Facebook: https://www.facebook.com/latestly/<br />Twitter: https://twitter.com/latestly<br />Instagram: https://www.instagram.com/latestly
